Interchangeability of Infanrix™ IPV/Hib and Pediacel® at 2,4 & 6 Months of Age
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00990080|
Recruitment Status : Completed
First Posted : October 6, 2009
Last Update Posted : June 15, 2011
IWK Health Centre
MCM Vaccines B.V.
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||July 2010|
|Actual Study Completion Date :||January 2011|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Langley JM, Halperin SA, Rubin E, White C, McNeil S, Mutch J, Mackinnon-Cameron D, Smith B. Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial. Pediatr Infect Dis J. 2012 Feb;31(2):189-92. doi: 10.1097/INF.0b013e318242462a.